Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized, Open-Label, Multi-Center Study to Evaluate the Efficacy and Safety of Multiple Roxadustat Dosing Regimens for the Treatment of Anemia in Dialysis Subjects With Chronic Kidney Disease

NCT04059913 is registered in ClinicalTrials.gov with Kyntra Bio as lead sponsor.

NCT NCT04059913
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04059913 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized, Open-Label, Multi-Center Study to Evaluate the Efficacy and Safety of Multiple Roxadustat Dosing Regimens for the Treatment of Anemia in Dialysis Subjects With Chronic Kidney Disease
Lead sponsor
Kyntra Bio
Phase
Phase 4
Overall status
Completed
Start date
June 11, 2019
Completion date
December 17, 2021
Enrollment
318 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

ckd anemia in dialysis participants